Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals

NCT ID: NCT06844097

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-07

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The team aims to test the effectiveness of an intervention to increase gender-affirming cervical cancer prevention behaviors targeted at medical students studying in Puerto Rico and Florida. The team expects that after exposure to the intervention, relative to the control group, participants in the experimental condition will manifest more favorable changes in knowledge, attitudes, and behaviors of adequate care towards Latinx transmasculine and non-binary people.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transmen (TM) and non-binary individuals (NB; individuals assigned female sex at birth who identify as a man, male, or another diverse non-binary gender identity on the masculine spectrum) are at higher risk of screening-detectable cancers. Latinx TM-NB (LTM-NB) are at a higher risk for cervical cancer (CC) as they intersect two health disparity populations with high risk for this type of cancer (gender identity and ethnic minorities). Despite CC being highly preventable, LTM-NB individuals have been found to have lower rates of CC screening than cisgender female patients (persons who are not transgender). Unfortunately, findings from the team's previous funded studies with LTM-NB individuals in Puerto Rico (PR) and Florida evidence that providers lack knowledge regarding LTM-NB individual's healthcare needs, have negative stigmatizing attitudes, and manifest discriminatory behaviors in clinical interactions with LTM-NB individuals; which greatly limits their ability for engaging in recommended education and prevention guidelines of care for CC screening and prevention. In light of this, the research team (community stakeholders from PR and Mainland US, researchers, and providers) has developed a brief online intervention to improve medical students' competencies for cervical cancer education and screening promotion among LTM-NB individuals.

The proposed study aims to: 1) Test the effectiveness of the intervention in increasing medical students' knowledge, attitudes, and skills for providing healthcare to LTM-NB. , 2) Determine the acceptability, appropriateness, and feasibility of implementing the interventions in real-world medical educational settings.

While the team has preliminary data regarding the efficacy of the intervention, this pilot is proposing a rigorous study design: Aim 1 will measure the magnitude of effect of the intervention, and Aim 2 measures the implementation. This study will address cervical cancer disparities among LTM-NB individuals. The impact of this study will reveal new effective interventions and implementation strategies. The translational implications of this work will result in providing medical schools with a cross-cultural tool to train students on cervical cancer prevention for LTM-NB individuals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clinical Competence Medical Education Cervical Cancer Screening

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

Participants assigned to the experimental condition will receive the CC-TRAINED intervention.

Group Type EXPERIMENTAL

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

Intervention Type BEHAVIORAL

An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.

Disaster Preparedness Course

Participants randomized to the control condition will receive a Disaster Preparedness Course, addressing the basics of natural disaster preparedness

Group Type OTHER

Disaster Preparedness Course

Intervention Type BEHAVIORAL

An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.

Intervention Type BEHAVIORAL

Disaster Preparedness Course

An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical student currently in third year of medical school training

Exclusion Criteria

* Do not speak English
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

Sponsor Role collaborator

Ponce Medical School Foundation, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alixida Ramos Pibernus, PhD

Role: PRINCIPAL_INVESTIGATOR

Ponce Health Sciences University

Matthew B Schabath, PhD

Role: PRINCIPAL_INVESTIGATOR

H. Lee Moffit Cancer Center and Research Institute

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alixida Ramos-Pibernus, PhD

Role: CONTACT

787-840-2575

Matthew B Schabath, PhD

Role: CONTACT

813-745-4150

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2U54CA163071-11

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2308159535R001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.